PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS

PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS

The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide co-crystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribut...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Konosonoks Armands, Merkys Kestutis
Format: Patent
Sprache:eng ; slv
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Konosonoks Armands
Merkys Kestutis
description The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide co-crystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging form 1µm to 100µm.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_SI3135275TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>SI3135275TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_SI3135275TT13</originalsourceid><addsrcrecordid>eNqNjEEKwjAQRbtxIeodxgO4qKW4HtOUDiSZkEwLrkqRuCpaqPfHVjyAqw__vf-32egbDBaVboUUGlBsPUcSYgcKPV6NBq5BGg3kFAfPAb9wKY12aKhiS9VKocNA3EZQ4RYFjSGnwXJF9fK8buI-2zyGcU6HX-6yY61FNac0vfo0T8M9PdO7j1TkRXm-lCJ58Y_zATjNN5g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS</title><source>esp@cenet</source><creator>Konosonoks Armands ; Merkys Kestutis</creator><creatorcontrib>Konosonoks Armands ; Merkys Kestutis</creatorcontrib><description>The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide co-crystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging form 1µm to 100µm.</description><language>eng ; slv</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200930&amp;DB=EPODOC&amp;CC=SI&amp;NR=3135275T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20200930&amp;DB=EPODOC&amp;CC=SI&amp;NR=3135275T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Konosonoks Armands</creatorcontrib><creatorcontrib>Merkys Kestutis</creatorcontrib><title>PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS</title><description>The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide co-crystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging form 1µm to 100µm.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjEEKwjAQRbtxIeodxgO4qKW4HtOUDiSZkEwLrkqRuCpaqPfHVjyAqw__vf-32egbDBaVboUUGlBsPUcSYgcKPV6NBq5BGg3kFAfPAb9wKY12aKhiS9VKocNA3EZQ4RYFjSGnwXJF9fK8buI-2zyGcU6HX-6yY61FNac0vfo0T8M9PdO7j1TkRXm-lCJ58Y_zATjNN5g</recordid><startdate>20200930</startdate><enddate>20200930</enddate><creator>Konosonoks Armands</creator><creator>Merkys Kestutis</creator><scope>EVB</scope></search><sort><creationdate>20200930</creationdate><title>PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS</title><author>Konosonoks Armands ; Merkys Kestutis</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_SI3135275TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; slv</language><creationdate>2020</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Konosonoks Armands</creatorcontrib><creatorcontrib>Merkys Kestutis</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Konosonoks Armands</au><au>Merkys Kestutis</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS</title><date>2020-09-30</date><risdate>2020</risdate><abstract>The present invention relates to pharmaceutical compositions comprising the active substance Lenalidomide in one of the modifications selected from Lenalidomide base, a Lenalidomide salt, a Lenalidomide co-crystal or mixtures thereof, wherein the Lenalidomide particles have a particle size distribution (d90) ranging form 1µm to 100µm.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; slv
recordid cdi_epo_espacenet_SI3135275TT1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title PHARMACEUTICAL COMPOSITION CAPABLE OF THE INCORPORATION OF LENALIDOMIDE IN VARIOUS CRYSTALLINE MODIFICATIONS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T18%3A53%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Konosonoks%20Armands&rft.date=2020-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ESI3135275TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true